[This corrects the article DOI: 10.3389/fcell.2021.652065.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521206 | PMC |
| http://dx.doi.org/10.3389/fcell.2021.770837 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Exploring the interactions between engineered nanomaterials and immune cells at 3D nano-bio interfaces to discover potent nano-adjuvants" [Nanomed.: Nanotechnol. Biol. Med. 21C (2019) 102037].
Nanomedicine
December 2024
State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, Jiangsu, China. Electronic address:
Corrigendum to "Jingfang Granule mitigates Coxsackievirus B3-induced myocardial damage by modulating mucolipin 1 expression" [J. Ethnopharmacol. 320 (2024) 117396].
J Ethnopharmacol
February 2025
Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China. Electronic address:
Corrigendum to "Mitigating phospholipid peroxidation of macrophages in stress-induced tumor microenvironment by natural ALOX15/PEBP1 complex inhibitors".
Phytomedicine
November 2024
Guangdong Second Provincial General Hospital/Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug D evelopment of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research/Integrated Chinese and Western Medicine Postdoctoral Research Station/State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou 510632, China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China. Electronic address:
Corrigendum to "Combined sulforaphane and β-sitosterol mitigate against olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways" [Int. Immunopharmacol. 140 (2024) 112904].
Int Immunopharmacol
December 2024
Pharmacology and Toxicology Department, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt; Pharmacology and Toxicology Department, Faculty of Pharmacy, Al-Ayen Iraqi University, Thi-Qar 64001, Iraq.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!